Octride DEPOT 30mg

Octride DEPOT 30 is a prescription medication used to treat certain types of cancer, including carcinoid tumors and metastatic glucagonoma. It is a synthetic analog of somatostatin, which is a hormone that helps to regulate various bodily functions.

Composition:

• Octreotide 30mg/mL

Mechanism of Action:

Octreotide works by:

1. Binding to somatostatin receptors on the surface of cancer cells, which can help to slow down the growth and proliferation of these cells
2. Inhibiting the release of hormones that can stimulate the growth of cancer cells
3. Reducing the symptoms associated with carcinoid tumors, such as diarrhea and flushing

Indications:

Octride DEPOT 30 is approved for the treatment of:

• Carcinoid tumors, including those that are unresectable or metastatic
• Metastatic glucagonoma, a type of pancreatic cancer that secretes excessive amounts of glucagon
• Acromegaly, a condition caused by excess growth hormone production

Dosage:

The recommended dosage of Octride DEPOT 30 is:

• 30mg administered as an intramuscular injection every 4 weeks
• The recommended duration of treatment is until disease progression or unacceptable toxicity occurs

Side Effects:

Common side effects of Octride DEPOT 30 include:

1. Pain or swelling at the injection site
2. Nausea and vomiting
3. Abdominal pain
4. Diarrhea
5. Headache
6. Fatigue
7. Muscle weakness
8. Increased risk of infections

Recommendation:

Octride DEPOT 30 is recommended for patients with carcinoid tumors, metastatic glucagonoma, or acromegaly who have not responded to other treatments.

Important Note:

• Patients taking Octride DEPOT 30 should be closely monitored for signs of liver toxicity or gallstones.
• Patients taking Octride DEPOT 30 should avoid taking medications that may interact with it, such as blood thinners or medications that can increase the risk of bleeding.
• Pregnant or breastfeeding women should not use Octride DEPOT 30, as it may harm the fetus or infant.
• Regular follow-up appointments with your healthcare provider are necessary to monitor the effectiveness of Octride DEPOT 30 and to detect any potential side effects or complications.

Special Precautions:

• Patients with a history of liver disease or kidney disease should be closely monitored while taking Octride DEPOT 30.
• Patients with a history of gallstones should be closely monitored while taking Octride DEPOT 30.

Contraindications:

• Patients who are allergic to octreotide or any other component of Octride DEPOT 30 should not use it.
• Patients who are pregnant or breastfeeding should not use Octride DEPOT 30.
• Patients with severe liver disease or severe kidney disease should not use Octride DEPOT 30.

Warnings:

• Octride DEPOT 30 can cause liver toxicity, which can lead to elevated liver enzymes and liver damage.
• Patients with a history of liver disease should be closely monitored while taking Octride DEPOT 30.
• Patients should report any changes in their liver function tests or symptoms of liver toxicity to their healthcare provider immediately.